학술논문

88TiP A phase Ib study of HMBD-001, a monoclonal antibody targeting HER3, with or without chemotherapy in patients with genetic aberrations in HER3 signaling.
Document Type
Article
Source
Annals of Oncology. 2023 Supplement 4, Vol. 34, pS1501-S1501. 1p.
Subject
*MONOCLONAL antibodies
*CANCER chemotherapy
Language
ISSN
0923-7534